Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.

Poitiers University Hospital

Status and phase

Terminated

Phase 3

Conditions

Pain

Treatments

Drug: nitrous oxide and oxygen

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT00219713

991300

Details and patient eligibility

About

Bone marrow biopsy is a painful medical procedure often performed with local anesthetic.

Therefore a double-blind, randomized, controlled trial was carried out in 330 adult patients who where referred for bone marrow biopsy and aspiration. 164 were assigned to inhale an equimolar mixture of nitrous oxide and oxygen and 166 to inhale a placebo. Pain measurement used visual-analogue pain scales, which involve rating the intensity of pain on a horizontal ruler

Full description

The efficacy of an inhaled equimolar mixture of nitrous oxide and oxygen to prevent procedural pain during lumbar puncture in children has been demonstrated. In adults the use of an inhaled equimolar mixture could prevent pain.

Although nitrous oxide was initially considered innocuous, evidence began to be gathered later that it had potentially side effect. It has been demonstrated that nitrous oxide inactivates the vitamin B12-dependent enzyme methionine synthetase and impairs DNA synthesis in bone marrow cells.

Therefore this prospective, multicenter randomized placebo controlled, double-blind trial was design to determine whether an inhaled equimolar mixture of nitrous oxide and oxygen would significantly reduce pain during bone marrow biopsy with aspiration. In addition we performed a careful cytological examination of bone marrow samples in order to evaluate the quality of the picture sample.

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients 18 years of age or older
with a good clinical condition (score ECOG < 2)
without contra indication for the use of nitrous oxide or previous medical history of allergy to Xylocaïne.
Informed consent signed up.

Exclusion criteria

pregnancy,
prior exposure to nitrous oxide,
patients with neurological illness and those on anti depressant medications or with congestive heart failure or significant respiratory disease.
patients on analgesia for other medical conditions or whose with the inability to provided consent of an assessment of pain.
patients with platelet dysfunction or related coagulation disorders, aspirin or warfarin therapy